Short answer
Olema Pharmaceuticals, Inc. (OLMA) filed an 8-K current report with the SEC on October 15, 2026 reporting Item 5.02 (Departure/Election of Directors or Officers). Dr. Gorjan Hrustanovic resigned from the Board effective October 14, 2026.
Olema Pharmaceuticals, Inc. 8-K event analysis
AI summary of each reported item and its exhibits
Item 5.02 · Departure/Election of Directors or Officers
- Dr. Gorjan Hrustanovic resigned from the Board effective October 14, 2026
- Committee departures included Compensation and Science and Technology committees
- Resignation unrelated to disagreements over operations, policies or practices
- Dr. Prakash Raman appointed to both committees effective October 15, 2026
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other Olema Pharmaceuticals, Inc. 8-K filings
Get the next OLMA 8-K as it lands
Follow OLMA for push alerts, or ask the research agent what this filing means.